FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/055120 [Registered on: 12/07/2023] Trial Registered Prospectively
Last Modified On: 09/09/2023
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Nutraceutical 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Efficacy of Turmeric-boswellia extract in subjects with low back discomfort. 
Scientific Title of Study   A randomized double-blinded placebo-controlled study to determine the efficacy of Turmeric-Boswellia formulation on subjects with low back soreness and discomfort. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
AN-06PFK0623H3-WES15 version 1, date 1 Jun 2023  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Binu T Kuruvilla 
Designation  Chief Innovation Officer 
Affiliation  Arjuna Natural Pvt Ltd 
Address  Arjuna Natural Pvt Ltd Bank Road, Aluva Ernakulam

Ernakulam
KERALA
683101
India 
Phone  09447818432  
Fax    
Email  drbinu@arjunanatural.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Binu T Kuruvilla 
Designation  Chief Innovation Officer 
Affiliation  Arjuna Natural Pvt Ltd 
Address  Arjuna Natural Pvt Ltd Bank Road, Aluva Ernakulam

Ernakulam
KERALA
683101
India 
Phone  09447818432  
Fax    
Email  drbinu@arjunanatural.com  
 
Details of Contact Person
Public Query
 
Name  Sooraj Rajasekharan Kartha 
Designation  Scientist- Clinical Research 
Affiliation  Arjuna Natural Pvt Ltd 
Address  Arjuna Natural Pvt Ltd Bank Road, Aluva Ernakulam

Ernakulam
KERALA
683101
India 
Phone  9847670997  
Fax    
Email  sooraj@arjunanatural.com  
 
Source of Monetary or Material Support  
Arjuna Natural Pvt Ltd Bank Road, Aluva Ernakulam 683101 KERALA  
 
Primary Sponsor  
Name  Arjuna Natural Private Ltd 
Address  Arjuna Natural Pvt Ltd Bank Road, Aluva Ernakulam KERALA 
Type of Sponsor  Other [Nutraceutical] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ajay Gupta  Nirmal Hospital  Dept of orthopedics, OPD Room no: 1, Ground Floor, Opp MLB Medical college, Gate no. 3
Jhansi
UTTAR PRADESH 
9005665599

ajaygupt70@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Nirmal Hospital Institutional Ethics committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Posture related low back discomfort  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Placebo  polysorbate-80 and PEG400 in 500mg soft gel capsules once daily for 15 days.  
Intervention  Turmeric-Boswellia extract  Turmeric-Boswellia extract in sesame oil 500mg soft gel capsules once daily for 15 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Male or female 18 to 70 years of age
Posture related low back pain
NRS score greater than 5 pain at the time of screening.
BMI 18 to 29kg/m2 
 
ExclusionCriteria 
Details  History of herniated or ruptured disc, Sciatica, inflammatory arthropathy, severe rheumatoid arthritis, severe osteoarthritis, fibromyalgia, gout, kidney infection, failure or stones, scoliosis or spondylolisthesis, Past injuries like fractures, tears or trauma to the spine, and tumour or spinal cancer.
Acute 48-hour pain due to some exercise.
Knee surgery within the past 6 months, expectations of surgery in the next 4 months, Intra-articular corticosteroid injections within the preceding 3 months.
No neurological symptoms like numbness or weakness in the legs. Muscle pain does not involve compression or irritation of the spinal nerves.
BMI greater or eqaul to 30
High alcohol intake greater than 2 standard drinks per day
Smoking status not more than 1 pack per day
Concomitant medications antibiotics, NSAIDS, steroids, OTC pills and ointments for pain 1 week before screening. Patients taking any joint pain supplements
 
 
Method of Generating Random Sequence   Stratified randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Mean change in the Sum of pain intensity difference at 6 hours  Day 1, 7, 15 
 
Secondary Outcome  
Outcome  TimePoints 
Mean change in Total pain relief at 6 hours  Day 1, 7, 15 
Mean change in Oswestry Disability Index  Day 1, 7, 15 
 
Target Sample Size   Total Sample Size="52"
Sample Size from India="52" 
Final Enrollment numbers achieved (Total)= "52"
Final Enrollment numbers achieved (India)="52" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   21/07/2023 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

 The lower back is one of the most affected part in the posture related pain associated with work/lifestyle habits. This is different from the acute pain originating from exercise which arises within 48 hours. The lower back pain from posture starts mildly and progresses to moderate to severe pain and lasts for weeks or till the posture or lifestyle is changed. Turmeric-boswellia extract has excellent pain reliving properties and this study looks to determine its pain relieving properties in low back soreness and discomfort caused by posture. This study includes subjects having pain for at least last 2-3 weeks having an NRS score of greater than or equal to 5 at the time of screening. This study excludes disc related and lower limb related pain and other systemic illnesses. A mean change in the SPID at 6hrs is the primary end point and the study duration is of 15 days.

 
Close